查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829715

2025年全球髂動脈支架市場報告

Iliac Stent Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，髂動脈支架市場規模強勁成長，從2024年的10.2億美元成長至2025年的10.9億美元，複合年成長率為6.5%。預測期內的成長可歸因於全球醫療保健行業的擴張、人們對微創手術的認知不斷提高、支架置入手術需求的不斷成長、髂動脈疾病患病率的上升以及醫療基礎設施的改善。

預計未來幾年髂動脈支架市場規模將強勁成長，到2029年將達到14.1億美元，複合年成長率為6.8%。預測期內的成長可歸因於許多因素，例如周邊動脈疾病盛行率的上升、老年人口的成長、血管成形術數量的增加、對微創手術的需求不斷成長以及糖尿病盛行率的上升。預測期內的主要趨勢包括髂動脈支架技術的進步、產品核可的增加、醫療技術的進步、分銷網路的擴展以及髂動脈支架在門診病人環境中的普及。

髂動脈支架是專門用於治療骨盆腔髂動脈粥狀硬化的醫療設備。這些支架透過類似血管成形術的微創手術置入，以打開並支撐狹窄或阻塞的動脈。

髂動脈支架的主要類型包括自動擴張型支架、球囊擴張型支架等。自動擴張型支架是一種醫療器械，用於治療身體各部位狹窄或阻塞的血管，包括冠狀動脈、周邊動脈和其他管狀結構。它們可用於治療各種動脈病變，例如髂總動脈病變、嚴重鈣化病變和完全阻塞。這些支架的最終用戶包括醫院和門診病人機構。

2025年春季美國關稅大幅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供髂動脈支架市場統計數據，例如全球市場規模、各地區市場佔有率、各競爭對手的髂動脈支架市場佔有率、詳細的髂動脈支架細分市場、市場趨勢以及髂動脈支架行業的商機，為您提供在髂動脈支架行業取得成功所需的數據。本髂動脈支架市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為6.8%，較我們先前對該市場的預測略有下降0.1%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會透過對來自巴西和愛爾蘭等主要地區的自膨式鎳鈦合金支架和藥物釋放型被覆劑徵收關稅直接影響美國，從而可能導致外周介入治療的延誤和血管手術成本的增加。

周邊動脈疾病的日益普及預計將在短期內推動髂動脈支架市場的擴張。周邊動脈疾病（PAD）是一種血管疾病，其特徵是心臟和腦外動脈變窄或阻塞，通常由吸煙、老化、高血壓和糖尿病等因素引起。髂動脈置入術已成為 PAD 患者的有效治療方法，可改善血流、緩解症狀並減少併發症，並且是一種微創且成功率很高的手術。例如，根據心血管血管造影術和介入心血管疾病協會（SCAR）2023 年 7 月的數據，PAD 每年影響 800 萬至 1,000 萬美國人，預計到 2050 年將有 1,900 萬美國人患有 PAD。因此，周邊動脈疾病盛行率的上升是髂動脈支架市場發展的驅動力。

髂動脈支架市場的主要企業致力於創新iCast等產品，以改善患者預後並降低併發症的可能性。 iCast覆膜支架系統代表了治療髂動脈阻塞性疾病的新方法，與傳統的裸金屬支架相比，它具有卓越的性能並降低了併發症的風險。例如，2023年10月，Getinge宣布其iCast覆膜支架系統將在美國上市，該系統已獲得FDA核准用於治療髂動脈阻塞性疾病。這項進展凸顯了Getinge致力於為美國臨床醫生和醫院系統提供一流產品和支持，以有效管理這種嚴重的承諾。

2023年2月，雅培實驗室收購了心血管系統公司（CSI）。雅培實驗室的這項策略措施旨在透過整合CSI的創新動脈粥狀硬化斑塊切除術切除系統，增強其血管器械產品組合。心血管系統公司以其在醫療技術領域的貢獻而聞名，尤其是在髂動脈支架製造方面。

髂動脈支架市場的主要公司有 Cardinal Health Inc.、Abbott Laboratories、Medtronic Plc、Becton, Dickinson and Company、Boston Scientific Corporation、B. Braun Melsungen AG、Terumo Corporation、W.L. Gore &Associates Inc.、C.R. Bard Inc.、Cortinge、Cook Medical. Corporation、Endologix Inc.、LeMaitre Vascular Inc.、Alvimedica、Clearstream Technologies Ltd.、Jotec GmbH、Translumina GmbH、Vascular Concepts Limited、Lombard Medical Technologies、Acandis GmbH、Gore Medical 和 Medizintechnik GmbH。

2024年，北美是髂動脈支架市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。髂動脈支架市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

髂動脈支架市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、英國、加拿大、義大利和西班牙。

髂動脈支架市場包括冠狀動脈支架、膽道支架和輸尿管支架的銷售。該市場的價值是指“出廠價”，即產品製造商或生產商銷售的產品價值，無論是銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球髂動脈支架：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球髂動脈支架市場：成長率分析
  • 全球髂動脈支架市場表現：規模與成長，2019-2024
  • 全球髂動脈支架市場預測：規模與成長，2024-2029，2034
  • 全球髂動脈支架：總目標市場（TAM）

第6章 市場細分

  • 全球髂動脈支架市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 自動擴張型支架
  • 球囊擴張型支架
  • 其他類型
  • 全球髂動脈支架市場（按動脈病變、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 髂總動脈病變
  • 嚴重鈣化病變
  • 完全閉塞性病變
  • 全球髂動脈支架市場（按最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診設施
  • 其他最終用戶
  • 全球髂動脈支架市場：自動擴張型支架（按類型）、績效及預測，2019-2024、2024-2029、2034
  • 鎳鈦合金自動擴張型支架
  • 聚合物塗層自動擴張型支架
  • 全球髂動脈支架市場：球囊擴張型細分（依類型）、績效及預測，2019-2024、2024-2029、2034
  • 裸金屬球囊擴張型支架
  • 藥物釋放型球囊擴張型支架
  • 全球髂動脈支架市場：按類型（其他）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 覆膜支架
  • 混合支架

第7章 區域和國家分析

  • 全球髂動脈支架市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球髂動脈支架市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 髂動脈支架市場：競爭格局
  • 髂動脈支架市場：公司簡介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • B. Braun Melsungen AG
  • Terumo Corporation
  • WL Gore & Associates Inc
  • CR Bard Inc.
  • Getinge AB
  • Cook Medical LLC
  • Biotronik SE & Co. KG
  • MicroPort Scientific Corporation
  • Cordis Corporation
  • Endologix Inc.
  • LeMaitre Vascular Inc.
  • Alvimedica
  • Clearstream Technologies Ltd.
  • Jotec GmbH
  • Translumina GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年髂動脈支架市場：提供新機會的國家
  • 髂動脈支架市場 2029：細分市場帶來新機會
  • 髂動脈支架市場 2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30441u

Iliac stents are specialized medical devices crafted to address atherosclerosis in the iliac arteries, situated in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to widen and provide support to narrowed or obstructed arteries.

The primary types of iliac stents include self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical instruments utilized for treating narrowed or obstructed blood vessels in various parts of the body, including the coronary arteries, peripheral arteries, and other tubular structures. They are employed in the treatment of various artery lesions such as common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. These stents are utilized by a range of end-users including hospitals, outpatient facilities, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The iliac stent market research report is one of a series of new reports from The Business Research Company that provides iliac stent market statistics, including iliac stent industry global market size, regional shares, competitors with an iliac stent market share, detailed iliac stent market segments, market trends, and opportunities, and any further data you may need to thrive in the iliac stent industry. This iliac stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iliac stent market size has grown strongly in recent years. It will grow from $1.02 billion in 2024 to $1.09 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to expansion of the global healthcare industry, increased awareness about minimally invasive procedures, increased demand for stenting procedures, rise in incidence of iliac artery diseases, improved healthcare infrastructure.

The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.41 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing prevalence of peripheral artery diseases, growing geriatric population, increasing angioplasty operations, rise in the need for less intrusive operations, rising incidence of diabetes. Major trends in the forecast period include technological advancements in iliac stents, increasing number of product approvals, advancements in medical technology, expanding distribution networks, adoption of iliac stents in outpatient settings.

The forecast of 6.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on self-expanding nitinol scaffolds and drug-eluting coatings, sourced from key regions such as Brazil and Ireland, which could lead to delayed peripheral artery interventions and increased vascular surgery expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of peripheral artery diseases is anticipated to drive the expansion of the iliac stent market in the foreseeable future. Peripheral artery disease (PAD) is a vascular condition characterized by the narrowing or blockage of arteries outside the heart and brain, often attributed to factors such as smoking, an aging population, hypertension, and diabetes. Iliac stenting emerges as a valuable treatment modality for PAD patients, offering enhanced blood flow, relief from symptoms, and mitigation of complications, all while being minimally invasive and boasting a high success rate. For instance, as per data from the Society for Cardiovascular Angiography and Interventions in July 2023, PAD affects 8-10 million Americans annually, with projections estimating 19 million Americans to be affected by PAD by 2050. Hence, the escalating prevalence of peripheral artery diseases serves as a driving force for the iliac stent market.

Key players in the iliac stent market are dedicated to innovating products such as iCast to elevate patient outcomes and diminish the likelihood of complications. The iCast-covered stent system signifies a novel approach to addressing iliac artery occlusive disease, offering superior performance and a reduced risk of complications compared to conventional bare-metal stents. For instance, in October 2023, Getinge announced the US commercial availability of the iCast-covered stent system, FDA-approved for treating iliac arterial occlusive disease. This development underscores Getinge's commitment to furnishing US clinicians and hospital systems with top-tier products and support for managing this critical condition effectively.

In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems Inc. (CSI) for an undisclosed sum. This strategic move by Abbott Laboratories aims to enrich its vascular device portfolio by integrating CSI's innovative atherectomy system. Cardiovascular Systems Inc. is renowned for its contributions in the realm of medical technology, particularly in manufacturing iliac stents.

Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

North America was the largest region in the iliac stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iliac stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iliac Stent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iliac stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iliac stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The iliac stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Self-Expandable Stents; Balloon-Expandable Stents; Other Types
  • 2) By Artery Lesions: Common Iliac Artery Lesions; Severe Calcified Lesions; Complete Obstructive Lesions
  • 3) By End-Users: Hospitals; Outpatient Facilities; Other End-Users
  • Subsegments:
  • 1) By Self-Expandable Stents: Nitinol Self-Expandable Stents; Polymer-Coated Self-Expandable Stents
  • 2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents; Drug-Eluting Balloon-Expandable Stents
  • 3) By Other Types: Covered Stents; Hybrid Stents
  • Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic Plc; Becton, Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; W. L. Gore & Associates Inc; C. R. Bard Inc.; Getinge AB; Cook Medical LLC; Biotronik SE & Co. KG; MicroPort Scientific Corporation; Cordis Corporation; Endologix Inc.; LeMaitre Vascular Inc.; Alvimedica; Clearstream Technologies Ltd.; Jotec GmbH; Translumina GmbH; Vascular Concepts Limited; Lombard Medical Technologies; Acandis GmbH; Gore Medical; Medizintechnik GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Iliac Stent Market Characteristics

3. Iliac Stent Market Trends And Strategies

4. Iliac Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Iliac Stent Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Iliac Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Iliac Stent Market Growth Rate Analysis
  • 5.4. Global Iliac Stent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Iliac Stent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Iliac Stent Total Addressable Market (TAM)

6. Iliac Stent Market Segmentation

  • 6.1. Global Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Expandable Stents
  • Balloon-Expandable Stents
  • Other Types
  • 6.2. Global Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Common Iliac Artery Lesions
  • Severe Calcified Lesions
  • Complete Obstructive Lesions
  • 6.3. Global Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Outpatient Facilities
  • Other End-Users
  • 6.4. Global Iliac Stent Market, Sub-Segmentation Of Self-Expandable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nitinol Self-Expandable Stents
  • Polymer-Coated Self-Expandable Stents
  • 6.5. Global Iliac Stent Market, Sub-Segmentation Of Balloon-Expandable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bare-Metal Balloon-Expandable Stents
  • Drug-Eluting Balloon-Expandable Stents
  • 6.6. Global Iliac Stent Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Covered Stents
  • Hybrid Stents

7. Iliac Stent Market Regional And Country Analysis

  • 7.1. Global Iliac Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Iliac Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Iliac Stent Market

  • 8.1. Asia-Pacific Iliac Stent Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Iliac Stent Market

  • 9.1. China Iliac Stent Market Overview
  • 9.2. China Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Iliac Stent Market

  • 10.1. India Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Iliac Stent Market

  • 11.1. Japan Iliac Stent Market Overview
  • 11.2. Japan Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Iliac Stent Market

  • 12.1. Australia Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Iliac Stent Market

  • 13.1. Indonesia Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Iliac Stent Market

  • 14.1. South Korea Iliac Stent Market Overview
  • 14.2. South Korea Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Iliac Stent Market

  • 15.1. Western Europe Iliac Stent Market Overview
  • 15.2. Western Europe Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Iliac Stent Market

  • 16.1. UK Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Iliac Stent Market

  • 17.1. Germany Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Iliac Stent Market

  • 18.1. France Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Iliac Stent Market

  • 19.1. Italy Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Iliac Stent Market

  • 20.1. Spain Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Iliac Stent Market

  • 21.1. Eastern Europe Iliac Stent Market Overview
  • 21.2. Eastern Europe Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Iliac Stent Market

  • 22.1. Russia Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Iliac Stent Market

  • 23.1. North America Iliac Stent Market Overview
  • 23.2. North America Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Iliac Stent Market

  • 24.1. USA Iliac Stent Market Overview
  • 24.2. USA Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Iliac Stent Market

  • 25.1. Canada Iliac Stent Market Overview
  • 25.2. Canada Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Iliac Stent Market

  • 26.1. South America Iliac Stent Market Overview
  • 26.2. South America Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Iliac Stent Market

  • 27.1. Brazil Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Iliac Stent Market

  • 28.1. Middle East Iliac Stent Market Overview
  • 28.2. Middle East Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Iliac Stent Market

  • 29.1. Africa Iliac Stent Market Overview
  • 29.2. Africa Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Iliac Stent Market Competitive Landscape And Company Profiles

  • 30.1. Iliac Stent Market Competitive Landscape
  • 30.2. Iliac Stent Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Iliac Stent Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. W. L. Gore & Associates Inc
  • 31.4. C. R. Bard Inc.
  • 31.5. Getinge AB
  • 31.6. Cook Medical LLC
  • 31.7. Biotronik SE & Co. KG
  • 31.8. MicroPort Scientific Corporation
  • 31.9. Cordis Corporation
  • 31.10. Endologix Inc.
  • 31.11. LeMaitre Vascular Inc.
  • 31.12. Alvimedica
  • 31.13. Clearstream Technologies Ltd.
  • 31.14. Jotec GmbH
  • 31.15. Translumina GmbH

32. Global Iliac Stent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iliac Stent Market

34. Recent Developments In The Iliac Stent Market

35. Iliac Stent Market High Potential Countries, Segments and Strategies

  • 35.1 Iliac Stent Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Iliac Stent Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Iliac Stent Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer